http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-2617493-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_afd115dec46c157d3739020ebd4d866b |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-42 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-1709 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-42 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-17 |
| filingDate | 1976-04-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_04d5f34e52fb53340ffd413b8a08661f |
| publicationDate | 1977-11-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | DE-2617493-A1 |
| titleOfInvention | MEDICINAL PRODUCTS FOR THE PROPHYLAXIS AND THERAPY OF CEREBRAL VASOSPASMS |
| abstract | Medicaments for the prophylaxis and therapy of cerebral vasospasms contain haptoglobin (Hp) or a haemoglobin-haptoglobin (Hb-Hp) complex. The Hp or Hb-Hp complex is pref. used in the form of an isotonic soln. This can be applied locally by periodically rinsing the spastic artery during surgery, or can be administered by intraventricular or intrathecal infusion. Suitable Hp prepns. can be prepd. by purification of alpha2-globulin. The medicaments can be used to control oxyhaemoglobin-induced vasospasms during surgical aneurismectomy in cases of subarachnoid haemorrhage. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0767675-A4 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0767675-A1 |
| priorityDate | 1976-04-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 57.